Newron Pharmaceuticals
NWRN.SW
#8126
Rank
NZ$0.37 B
Marketcap
$19.47
Share price
-1.75%
Change (1 day)
26.60%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -NZ$31.25 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.01 Million. In 2023 the company made an earning of -NZ$31.25 Million, an increase over its 2022 earnings that were of -NZ$32.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-NZ$31.25 Million-4.45%
2022-NZ$32.71 Million11.19%
2021-NZ$29.42 Million-30.14%
2020-NZ$42.11 Million6.84%
2019-NZ$39.42 Million31.45%
2018-NZ$29.99 Million170.13%
2017-NZ$11.1 Million-60.23%
2016-NZ$27.91 Million-41.46%
2015-NZ$47.67 Million109.46%
2014-NZ$22.76 Million22.43%
2013-NZ$18.59 Million222.49%
2012-NZ$5.77 Million-60.49%
2011-NZ$14.59 Million-71%
2010-NZ$50.31 Million-17.37%
2009-NZ$60.88 Million52.58%
2008-NZ$39.9 Million41.24%
2007-NZ$28.25 Million-25.19%
2006-NZ$37.77 Million22.45%
2005-NZ$30.84 Million